Related Experiment Video
Updated: Aug 7, 2026

Multi-Modal Home Sleep Monitoring in Older Adults
Published on: January 26, 2019
[A 67-year-old patient with somnolence and severe hyponatraemia]
1Medizinische Klinik II - Grosshadern, Klinikum der Ludwig-Maximilians-Universität, München, Germany. julia.seiderer@med.uni-muenchen.de
Abstract:
A 67-year-old female patient with known depression was admitted to the intensive care unit with severe hyponatraemia (105 mmol/l) and somnolence caused by inadequate antidiuretic hormone secretion (SIADH) syndrome after starting therapy with the selective serotonin reuptake inhibitor (SSRI) Citalopram. This medication was stopped, and the hyponatraemia was carefully treated with fluid restriction and diuretics. Seven days later, the patient was discharged to a psychiatric ward with normal sodium levels and markedly improved vigilance. Given the increased use of SSRI for medical treatment of depression, the risk factors of this rare but potentially life-threatening complication and the diagnostic and therapeutic options are discussed.
Related Concept Videos
Hyperosmolar Hyperglycemic State
Heart Failure VI: Adjunct Therapies
Drug Dosing: Geriatric Patients
Narcolepsy
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Pharmacodynamics in Geriatric Patients: Effects of Age
